Pfizer Inc (PFE)

$25.70 +0.13 (0.51%)
Market Cap 143.00B
Revenue (ttm) 63.63B
Net Income (ttm) 8.03B
EPS (ttm) N/A
PE Ratio 7.86
Forward PE 7.92
Profit Margin 12.62%
Debt to Equity Ratio 0.66
Volume 35,453,900
Avg Vol 73,066,328
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 81%
Beta 0.46
Analysts Sell
Price Target $28.43

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and tre...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Willieberich
Willieberich Dec. 5 at 3:55 PM
$PFE conspiracy bot ...all garbage news ..
0 · Reply
Bluewin
Bluewin Dec. 5 at 3:53 PM
$MRNA $PFE should buy $MRNA
0 · Reply
Willieberich
Willieberich Dec. 5 at 3:53 PM
$PFE looks like someone finally opened there wallet..
0 · Reply
taxplanr
taxplanr Dec. 5 at 3:36 PM
Just in case you don't believe ACIP is closing the door on malignantRNA bioweapons from $BNTX $MRNA $PFE $NVAX there's this going on in FL courts https://www.josephsansone.com/p/mrna-bioweapons-prohibition-case-138?utm_source=post-email-title&publication_id=1021940&post_id=180755803&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Dec. 5 at 3:36 PM
$SLS as an FYI while we are waiting for Imminently DUE GPS Registrational Phase 3 Results... We will be Seeing Some data for SLS009 on Monday 009 is in the Same Class as Several Well Known Blockbusters: $SLS SLS009 - Tambiciclib CDKinase Inhibitor $PFE Pfizers' IBRANCE - Palbociclib CDKinase Inhibitor Novartis' KISQALI -Ribociclib CDKinase Inhibitor Eli Lilly's VERZENIO - Abemaciclib CDKinase Inhibitor - REGOR's Phase 1 - Phase 1 CDKinase Assets were bought for $850M in Cash +$4B More in Milestones. Just the Secondary SLS Asset is worth 10 -20x the current Market Cap.
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 3:16 PM
$CRMD: Dominating the niche, but can it fend off giants? DefenCath, the only FDA-approved CRBSI solution, is a key driver of $CRMD's robust growth, with $167.6M in sales in the first 9 months of 2025. However, looming competition from big players like $PFE and $AMPH could challenge its market lead. Discover why CRMD remains a Buy with a Zacks Rank #2 👉 https://www.zacks.com/stock/news/2800190/can-defencath-continue-to-aid-cormedixs-long-term-growth-ahead?cid=sm-stocktwits-2-2800190-body-23631&ADID=SYND_STOCKTWITS_TWEET_2_2800190_BODY_23631
1 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 5 at 3:14 PM
$PFE
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 5 at 2:43 PM
Enter: $PFE Calls Strike Price: $26 Expiry Date: DEC 26 2025 Buy in Price: $0.49 - $0.50 Sell Price: $0.92 Profit : +87% (Turn every $1 into $1.87) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Namhguab
Namhguab Dec. 5 at 2:38 PM
$PFE I have literally grown to hate this stock
1 · Reply
knuckleheadinvestco
knuckleheadinvestco Dec. 5 at 2:31 PM
$PFE let’s run to 26 this morning
0 · Reply
Latest News on PFE
Pfizer: The Market Is Still Wrong About It

Dec 5, 2025, 9:00 AM EST - 2 hours ago

Pfizer: The Market Is Still Wrong About It

17 dividend-stock bargains from a value manager with a stellar track record

Dec 2, 2025, 12:11 PM EST - 2 days ago

17 dividend-stock bargains from a value manager with a stellar track record

BMY CIVI CMCSA CVS MOS MRK MTH

2 Top Dividend Stocks to Buy Now and Hold For a Decade

Dec 2, 2025, 7:44 AM EST - 3 days ago

2 Top Dividend Stocks to Buy Now and Hold For a Decade

ABBV

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

Dec 1, 2025, 3:50 PM EST - 3 days ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA NVAX

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

Dec 1, 2025, 12:35 PM EST - 3 days ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA NVAX

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

Dec 1, 2025, 10:00 AM EST - 4 days ago

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

2 Undervalued, High-Quality Companies to Buy Now and Hold Forever

Nov 30, 2025, 9:05 PM EST - 4 days ago

2 Undervalued, High-Quality Companies to Buy Now and Hold Forever

BMY

This 7% Yielder Could Be a Top AI Play

Nov 30, 2025, 4:04 PM EST - 4 days ago

This 7% Yielder Could Be a Top AI Play

3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio

Nov 30, 2025, 6:30 AM EST - 5 days ago

3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio

JNJ MDT

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

Nov 30, 2025, 6:13 AM EST - 5 days ago

Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

Nov 29, 2025, 11:59 PM EST - 5 days ago

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

MA AVGO

8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills

Nov 28, 2025, 11:00 AM EST - 7 days ago

8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills

BBB BBY BMY CAG EQR KEY KIM

8 Dividend Stocks Every Investor Should Consider

Nov 28, 2025, 5:30 AM EST - 7 days ago

8 Dividend Stocks Every Investor Should Consider

ABBV AXP COST JPM NVDA PM SPGI

Have $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years

Nov 27, 2025, 4:01 AM EST - 8 days ago

Have $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years

HD JNJ O

Final Trade: DAL, AXP, PFE, HMY

Nov 26, 2025, 6:20 PM EST - 8 days ago

Final Trade: DAL, AXP, PFE, HMY

AXP DAL HMY

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings

Nov 26, 2025, 12:30 PM EST - 8 days ago

Valneva Posts Positive Lyme Vaccine Booster Results — Pfizer Targeting 2026 Regulatory Filings

VALN

Did Pfizer Just Say "Checkmate" to Novo Nordisk?

Nov 26, 2025, 4:15 AM EST - 9 days ago

Did Pfizer Just Say "Checkmate" to Novo Nordisk?

Is This the Best Value Stock to Buy While Markets Are Volatile?

Nov 25, 2025, 6:24 AM EST - 10 days ago

Is This the Best Value Stock to Buy While Markets Are Volatile?

Want Over $7,000 in Annual Dividends? Invest $25,000 in Each of These 4 Stocks.

Nov 25, 2025, 5:30 AM EST - 10 days ago

Want Over $7,000 in Annual Dividends? Invest $25,000 in Each of These 4 Stocks.

CAG UPS VZ

JNJ Stock vs. PFE Stock: Which Pharmaceutical Giant Is A Better Buy?

Nov 25, 2025, 5:20 AM EST - 10 days ago

JNJ Stock vs. PFE Stock: Which Pharmaceutical Giant Is A Better Buy?

JNJ

2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon

Nov 22, 2025, 9:20 AM EST - 13 days ago

2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon

VKTX

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

Nov 21, 2025, 1:24 PM EST - 13 days ago

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

This 7%-Yielding Dividend Stock Is About to Enter an Exciting New Phase

Nov 21, 2025, 8:00 AM EST - 14 days ago

This 7%-Yielding Dividend Stock Is About to Enter an Exciting New Phase

Pfizer Crosses Below Key Moving Average Level

Nov 20, 2025, 4:05 PM EST - 14 days ago

Pfizer Crosses Below Key Moving Average Level

$100,000 In The S&P 500's 5 Cheapest Healthcare Stocks, 4% Average Dividend Yield

Nov 20, 2025, 11:17 AM EST - 14 days ago

$100,000 In The S&P 500's 5 Cheapest Healthcare Stocks, 4% Average Dividend Yield

AMGN BMY GILD IVV MRK SPY VOO

Is Pfizer's 6.9%-Yielding Dividend Still Safe?

Nov 20, 2025, 9:30 AM EST - 15 days ago

Is Pfizer's 6.9%-Yielding Dividend Still Safe?

October Readers Identified 10 Ideal "Safer" Dividends In 39 Dogs

Nov 19, 2025, 5:43 PM EST - 15 days ago

October Readers Identified 10 Ideal "Safer" Dividends In 39 Dogs

CAG CIM EPD HAFN HRL IPG KEY

Pfizer: Is This Pharma Giant Finally A Bargain

Nov 19, 2025, 3:51 PM EST - 15 days ago

Pfizer: Is This Pharma Giant Finally A Bargain

Pfizer in $41.5 million settlement with Texas over ADHD drug

Nov 19, 2025, 10:31 AM EST - 16 days ago

Pfizer in $41.5 million settlement with Texas over ADHD drug

Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 19, 2025, 6:58 AM EST - 16 days ago

Pfizer Inc. (PFE) Presents at Jefferies London Healthcare Conference 2025 Transcript

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

Nov 18, 2025, 4:21 PM EST - 16 days ago

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

AZN JNJ LLY MDT MRK NVO OLMA

Global drugmakers rush to boost US presence as tariff threat looms

Nov 18, 2025, 8:25 AM EST - 17 days ago

Global drugmakers rush to boost US presence as tariff threat looms

ABBV AMGN AZN BIIB GILD GSK JNJ

2 No-Brainer Healthcare Stocks to Buy Now

Nov 18, 2025, 6:45 AM EST - 17 days ago

2 No-Brainer Healthcare Stocks to Buy Now

VKTX

Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?

Nov 17, 2025, 9:10 PM EST - 17 days ago

Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy?

US-Saudi event to include CEOs from Chevron, Qualcomm, Pfizer, source says

Nov 17, 2025, 6:54 PM EST - 17 days ago

US-Saudi event to include CEOs from Chevron, Qualcomm, Pfizer, source says

CVX QCOM CSCO GD

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

Nov 17, 2025, 4:05 PM EST - 17 days ago

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

INCY PPH VRTX XBI XLV

2 Giant Healthcare Stocks to Buy Hand Over Fist in November

Nov 17, 2025, 10:00 AM EST - 18 days ago

2 Giant Healthcare Stocks to Buy Hand Over Fist in November

MDT

Down 55%, Should You Buy the Dip on Pfizer?

Nov 17, 2025, 4:35 AM EST - 18 days ago

Down 55%, Should You Buy the Dip on Pfizer?

Is Pfizer Stock a Buy After This $10 Billion Acquisition?

Nov 15, 2025, 5:45 AM EST - 20 days ago

Is Pfizer Stock a Buy After This $10 Billion Acquisition?

Activist Starboard sells Pfizer stake after pushing for changes

Nov 14, 2025, 6:33 PM EST - 20 days ago

Activist Starboard sells Pfizer stake after pushing for changes

Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman

Nov 14, 2025, 3:19 PM EST - 20 days ago

Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman

ABBV AZN JNJ LLY MRK NVO XLV

Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race

Nov 13, 2025, 6:19 PM EST - 21 days ago

Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race

NVO

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

Nov 13, 2025, 5:20 PM EST - 21 days ago

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

BNTX

Pfizer CEO: RFK Jr. "clearly" was not his HHS Secretary choice

Nov 13, 2025, 2:16 PM EST - 21 days ago

Pfizer CEO: RFK Jr. "clearly" was not his HHS Secretary choice

Pfizer CEO: AI will help with medicine's next big breakthrough

Nov 13, 2025, 1:07 PM EST - 21 days ago

Pfizer CEO: AI will help with medicine's next big breakthrough

Pfizer Completes Acquisition of Metsera

Nov 13, 2025, 11:26 AM EST - 21 days ago

Pfizer Completes Acquisition of Metsera

MTSR

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

Nov 13, 2025, 11:10 AM EST - 21 days ago

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

BNTX

Metsera shareholders vote for $10 billion acquisition by Pfizer

Nov 13, 2025, 9:18 AM EST - 22 days ago

Metsera shareholders vote for $10 billion acquisition by Pfizer

MTSR

BioNTech says collaboration with Pfizer remains unchanged

Nov 13, 2025, 8:17 AM EST - 22 days ago

BioNTech says collaboration with Pfizer remains unchanged

BNTX

3 Healthcare Stocks Topping a 2025 List of Dividend Yields

Nov 12, 2025, 8:27 PM EST - 22 days ago

3 Healthcare Stocks Topping a 2025 List of Dividend Yields

BMY XRAY

Willieberich
Willieberich Dec. 5 at 3:55 PM
$PFE conspiracy bot ...all garbage news ..
0 · Reply
Bluewin
Bluewin Dec. 5 at 3:53 PM
$MRNA $PFE should buy $MRNA
0 · Reply
Willieberich
Willieberich Dec. 5 at 3:53 PM
$PFE looks like someone finally opened there wallet..
0 · Reply
taxplanr
taxplanr Dec. 5 at 3:36 PM
Just in case you don't believe ACIP is closing the door on malignantRNA bioweapons from $BNTX $MRNA $PFE $NVAX there's this going on in FL courts https://www.josephsansone.com/p/mrna-bioweapons-prohibition-case-138?utm_source=post-email-title&publication_id=1021940&post_id=180755803&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Dec. 5 at 3:36 PM
$SLS as an FYI while we are waiting for Imminently DUE GPS Registrational Phase 3 Results... We will be Seeing Some data for SLS009 on Monday 009 is in the Same Class as Several Well Known Blockbusters: $SLS SLS009 - Tambiciclib CDKinase Inhibitor $PFE Pfizers' IBRANCE - Palbociclib CDKinase Inhibitor Novartis' KISQALI -Ribociclib CDKinase Inhibitor Eli Lilly's VERZENIO - Abemaciclib CDKinase Inhibitor - REGOR's Phase 1 - Phase 1 CDKinase Assets were bought for $850M in Cash +$4B More in Milestones. Just the Secondary SLS Asset is worth 10 -20x the current Market Cap.
0 · Reply
ZacksResearch
ZacksResearch Dec. 5 at 3:16 PM
$CRMD: Dominating the niche, but can it fend off giants? DefenCath, the only FDA-approved CRBSI solution, is a key driver of $CRMD's robust growth, with $167.6M in sales in the first 9 months of 2025. However, looming competition from big players like $PFE and $AMPH could challenge its market lead. Discover why CRMD remains a Buy with a Zacks Rank #2 👉 https://www.zacks.com/stock/news/2800190/can-defencath-continue-to-aid-cormedixs-long-term-growth-ahead?cid=sm-stocktwits-2-2800190-body-23631&ADID=SYND_STOCKTWITS_TWEET_2_2800190_BODY_23631
1 · Reply
Micheal_Pothead
Micheal_Pothead Dec. 5 at 3:14 PM
$PFE
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Dec. 5 at 2:43 PM
Enter: $PFE Calls Strike Price: $26 Expiry Date: DEC 26 2025 Buy in Price: $0.49 - $0.50 Sell Price: $0.92 Profit : +87% (Turn every $1 into $1.87) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
Namhguab
Namhguab Dec. 5 at 2:38 PM
$PFE I have literally grown to hate this stock
1 · Reply
knuckleheadinvestco
knuckleheadinvestco Dec. 5 at 2:31 PM
$PFE let’s run to 26 this morning
0 · Reply
dogDazeSummer
dogDazeSummer Dec. 5 at 1:02 PM
$IFRX sure wld be nice if we had a little Gohibic on home turf w strongest approval. The right pharmaceutical company with the right marketing approach & EU distribution could generate value with this drug. The drug sales rep cld say: “would you like fries with that? (Sorry, US analogy)….OR “You know we also carry Gohibic now- wld u like 20 or 50 with this weeks order?” Easiest sale is a new product to existing customer (worst being new product to new—old customer). And prolly pick up entire company for reasonable cash ~$700-$1.1b Given timeline, the odds are growing by the day. BARDA, PG, Gohibic, next gen molecule are all “sleeper assets”. Patients/ Patience. $ABBV $PFE $RHHBY https://www.telegraph.co.uk/global-health/science-and-disease/eu-pre-pandemic-plan-to-stop-bird-flu-jumping-to-humans/
1 · Reply
Turkeymilitary
Turkeymilitary Dec. 5 at 7:42 AM
$ASBP $BAYRY $PFE $LLY
1 · Reply
bio1275
bio1275 Dec. 5 at 5:31 AM
$PFE unexpectedly well the last two trading sessions. good
0 · Reply
victorgn
victorgn Dec. 5 at 4:26 AM
$PFE $XOM $CVX https://dive2stocks.blogspot.com/2025/12/top-50-market-cap-stocks-in-low-25-of.html
0 · Reply
Jimmyboy29
Jimmyboy29 Dec. 5 at 3:53 AM
$PFE nice little bull flag for the 1month
0 · Reply
JoeTheMiner
JoeTheMiner Dec. 5 at 12:33 AM
$GUTS $SLS Bought again today at 1.9 This is a candidate for takeover for $PFE $NVO or $NVS I hope for a $5BILLION takeover. It is the perfect fit for drug like ozempic. Work in tandem Why peter Thiel is shareholder? 🤫🧐
3 · Reply
TQQQQ
TQQQQ Dec. 4 at 11:28 PM
$PFE https://stocktwits.com/news-articles/markets/equity/trump-administration-deadline-pharma-investments-to-end-of-term/cLIicqBREj4
0 · Reply
JoeTheMiner
JoeTheMiner Dec. 4 at 10:33 PM
$GUTS we are legion, We will see this raise to 8$ We will see have 50000 watchers Fasten your seat belt Hello $PFE , We welcome a takeover at 8$ GUTS has +30 patents
1 · Reply
Gps_100X_ROI_Potential
Gps_100X_ROI_Potential Dec. 4 at 9:24 PM
$SLS as an FYI while we are waiting for Imminently DUE GPS Registrational Phase 3 Results... We will be Seeing Some data for SLS009 on Monday 009 is in the Same Class as Several Well Known Blockbusters SLS009 - Tambiciclib CDKinase Inhibitor $PFE Pfizers' IBRANCE - Palbociclib CDKinase Inhibitor Novartis' KISQALI -Ribociclib CDKinase Inhibitor Eli Lilly's VERZENIO - Abemaciclib CDKinase Inhibitor and Don't Forget REGOR's Phase 1 CDKinase Asset was bought for $850M in Cash +$4B More in Milestones. Just the Secondary SLS Asset is worth 10 -20x the current Market Cap.
0 · Reply
BrendaGarrett356
BrendaGarrett356 Dec. 4 at 9:01 PM
$PFE offers a defensive edge - pharma + dividend stability make it a smart hedge if markets stay choppy or take a breather.
1 · Reply
ParabolicUptrends
ParabolicUptrends Dec. 4 at 8:55 PM
Micro float SNSE is getting a lot of attention! Could be the next crazy runner! Never chase those big runners that are up 100%+ .. Easy way to lose! Key is to buy early before the runs happen! 💎 These tiny float tickers are running 100-400% recently! SNSE starting to get discovered and trending on Stocktwits! Only 500k shares outstanding - keep it on watch bulls! Hold $CLOV $RVSN $INTC $PFE calls
1 · Reply
up2moon
up2moon Dec. 4 at 8:52 PM
$PFE What's up? Why are we not tanking as usual? And Lilly below trilly...😦
0 · Reply